EPSC 2027 Scientific Committee

The EPSC 2027 Scientific Committee is composed of highly respected leaders from across the global peptide community, bringing together internationally recognised experts from academia, biotechnology, pharmaceutical development, and peptide manufacturing. Their collective experience, scientific leadership, and long-standing contributions to the field help ensure that EPSC continues to deliver a world-class technical programme with genuine scientific and industrial value.


These individuals are widely regarded for their influence on peptide research, innovation, and education, and their involvement reflects the continued growth and reputation of EPSC within the international peptide sector.


We are especially honored to welcome Fernando Albericio as part of the Scientific Committee. Professor Albericio is recognised globally as one of the most influential figures in modern peptide science, with an extraordinary career spanning peptide chemistry, medicinal chemistry, drug discovery, and scientific publishing. His pioneering contributions to solid-phase peptide synthesis and peptide therapeutics have helped shape the direction of the field for decades, and his support and involvement in EPSC 2027 is greatly valued by the organising committee and wider peptide community alike.



Together, the Scientific Committee will help shape an engaging, forward-thinking programme that supports scientific collaboration, innovation, and practical advancements across the entire peptide lifecycle at EPSC 2027 in Málaga.

Elisabetta Bianchi


Director - Discovery Chemistry at Curium Pharma

Fernando Albericio


Professor

University of KwaZulu-Natal

Jonathan Collins


Vice President Business Development CEM Corporation